FungLyn Biotech Corp. Ltd

FungLyn Biotech Co., Ltd is committed to the developments of updated biotechnologies, molecular genetics diagnosis and biomedical research. It’s set up in 1999, finished FTC-2000TM qPCR (Real-Time Fluorescence Quantitative Thermalcycler) production in 2002 and upgraded its new generation in 2005 for global market. It owns itself and patents as well as new product R&D potentials. The enterprise is located in Shanghai city and gains much preference policy on tax; such as three-year tax free and five-year tax half axe. The business involved in following: (1) enlarger production and sales of FTC-2000TM qPCR (Real-Time Fluorescence Quantitative Thermalcycler) (the series for A,B and C products covered whole market ends from the high, the middle to the low consumers); (2)qPRC reagents and laboratory &PCR by-product; (3)New technology in bio-molecular detection& biomedicine R&D.

Due to the development of FTC-2000TM qPCR global market portion and for speeding up new product R&D, FungLyn Biotech is seeking for three million (US dollar) funds. Besides, there are some Nasda public companies which were paid interest in our project and forward to the acquisition or merger, the total investment for these operation approximately ten millions (USD).

Contact: Nie Xiaofeng

Tel: 021-64804931--802